Literature DB >> 19259309

Effective treatment strategies for cholangiocarcinoma: the challenge remains.

Diandra Ayala1, A William Blackstock.   

Abstract

Entities:  

Year:  2008        PMID： 19259309      PMCID： PMC2632560     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  10 in total

Review 1.  Biliary tract cancers.

Authors:  P C de Groen; G J Gores; N F LaRusso; L L Gunderson; D M Nagorney
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

2.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

3.  Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.

Authors:  Michel Kahaleh; Rajnish Mishra; Vanessa M Shami; Patrick G Northup; Carl L Berg; Penny Bashlor; Petra Jones; Kristi Ellen; Geoffrey R Weiss; Christiana M Brenin; Barbara E Kurth; Tyvin A Rich; Reid B Adams; Paul Yeaton
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02-06       Impact factor: 11.382

4.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

Authors:  L A Dawson; C J McGinn; D Normolle; R K Ten Haken; S Walker; W Ensminger; T S Lawrence
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

5.  Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.

Authors:  Edgar Ben-Josef; Daniel Normolle; William D Ensminger; Suzette Walker; Daniel Tatro; Randall K Ten Haken; James Knol; Laura A Dawson; Charlie Pan; Theodore S Lawrence
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

Review 6.  Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.

Authors:  William P Daines; Vandana Rajagopalan; Michael L Grossbard; Peter Kozuch
Journal:  Oncology (Williston Park)       Date:  2004-07       Impact factor: 2.990

Review 7.  The epidemiology of cholangiocarcinoma.

Authors:  Yasser Shaib; Hashem B El-Serag
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

8.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

9.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

Authors:  Yasser H Shaib; Jessica A Davila; Kathryn McGlynn; Hashem B El-Serag
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

10.  Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.

Authors:  Joseph M Baisden; Michel Kahaleh; Geoffrey R Weiss; Hilary Sanfey; Christopher A Moskaluk; Paul Yeaton; Eduard E de Lange; Tyvin A Rich
Journal:  Gastrointest Cancer Res       Date:  2008-09
  10 in total
  4 in total

Review 1.  Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma.

Authors:  Sergio A Gradilone; Maria J Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

2.  HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.

Authors:  Estanislao Peixoto; Sujeong Jin; Kristen Thelen; Aalekhya Biswas; Seth Richard; Manuela Morleo; Adrian Mansini; Stephanie Holtorf; Fabrizia Carbone; Nunzia Pastore; Andrea Ballabio; Brunella Franco; Sergio A Gradilone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-04-27       Impact factor: 4.052

3.  Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers.

Authors:  Kabir Mody; Jason Starr; Michelle Saul; Kelsey Poorman; Benjamin A Weinberg; Mohamed E Salem; Ari VanderWalde; Anthony F Shields
Journal:  J Gastrointest Oncol       Date:  2019-12

4.  A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin.

Authors:  Kabir Mody; Samuel O Antwi; David O Hodge; Sikander Ailawadhi; Lewis Roberts; Tanios Bekaii-Saab
Journal:  J Gastrointest Oncol       Date:  2018-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.